AFK Stock UPDATES Africa Index ETF Market Vectors (AFK) 32.31

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Africa Index ETF Market Vectors (AFK) 32.31 $AFK

Market Vectors(R) Egypt Index ETF (EGPT) and Africa Index ETF (AFK) to Begin Accruing for Potential Tax Liability
Business Wire - Thu Jul 17, 5:20PM CDT
In response to a 10% tax liability imposed by Egypt on dividends and capital gains from investments in Egyptian issuers, Market Vectors(R) Egypt Index ETF (NYSE Arca: EGPT(R)) and Market Vectors(R) Africa Index ETF (NYSE Arca: AFK(R)) will begin accruing for such tax effective July 18, 2014, it was announced today.

Behind the Recent Rise in the South Africa ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 7:00AM CDT
A look inside what has been driving the South Africa ETF higher lately.

Five Reasons to Change Your Outlook on Emerging Markets
at The Street - Thu Jun 19, 5:00AM CDT
Instead of lumping all emerging markets together, dig a little deeper to find the indexes and countries that can appreciate over the long haul. A quarter-to-quarter focus will only hurt your portfolio.

When Investing in Africa, Go Big Oil or Go Home
at The Street - Tue Mar 04, 5:00AM CST
With other oil companies pulling out of the continent, Sasol will solidify its base in Africa.

3 Ways to Profit From Growth in Africa
at The Street - Tue Feb 18, 5:00AM CST
Unilvever, Nestle, Total and Sasol should gain from African consumer demand.

These Are the World's 10 Most Optimistic Countries
Sean Williams, The Motley Fool - Motley Fool - Sat Jul 20, 6:00PM CDT
Have you ever had a bad day that was completely turned around because you were surrounding by a happy group of friends or co-workers? I know I have, and chances are you've experienced something similar as well. That's because happiness is contagious,...

3 Stocks Near 52-Week Lows Worth Buying
Sean Williams, The Motley Fool - Motley Fool - Tue Jul 16, 10:10AM CDT
Just as we examine companies each week that may be rising past their fair value , we can also find companies potentially trading at bargain prices. While many investors would rather have nothing to do with companies tipping the scales at 52-week...

MVIS Licenses GDP-Weighted Indices to Van Eck Global to Underlie ETFs
Business Wire - Mon Jun 24, 7:21AM CDT
Market Vectors Index Solutions GmbH (MVIS - www.marketvectorsindices.com) today announced the licensing of the Market Vectors GDP Africa Index (MVAFKTR) and the Market Vectors GDP GCC Index (MVMESTR) to Van Eck Global, the 7th largest provider of exchange-traded products in the US and the 10th largest globally. The indices replace the previous index benchmarks of Market Vectors Africa Index ETF (NYSE Arca: AFK) and Market Vectors Gulf States Index ETF (NYSE Arca: MES) which begin tracking the new benchmarks today, 24 June 2013.

Why You Should Avoid the South Africa ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri May 17, 5:30AM CDT
Should investors stay away from EZA and South Africa? The near term trends certainly aren't good on a number of fronts.

Investing in High Growth Africa
Blogs @ The Motley Fool - Motley Fool - Mon Mar 18, 11:50AM CDT
Africa, the world's poorest continent, is poised to grow fast in the decades to come. Some countries are finding ways to build more durable democratic institutions that can pave the way towards real development. War, famine and dictators...

ETFs To Tap Into 2013?s “Hidden Cities”
Daniela Pylypczak - ETFDB - Wed Jan 16, 8:00AM CST
As the ETF industry continues its rapid expansion, investors now have over 1,400 products to choose from to fit their every investment whim. But perhaps one of the key factors in selecting an appropriate fund is the level of diversification it offers...

Market Vectors ETFs Announces 2012 Distributions
Business Wire - Fri Dec 21, 7:08PM CST
The Market Vectors ETF Trust announced today the following 2012 annual distributions per share for the Market Vectors equity exchange-traded funds.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading